Yahoo Web Search

  1. Ads
    related to doubt
  1. Is Curaleaf Holdings (CNSX:CURA) A Risky Investment?

    Simply Wall St. via Yahoo FinanceOct 19 14:34 PM

    There's no doubt that we learn most about debt from the balance sheet.

  2. We Think BELLUS Health (TSE:BLU) Can Afford To Drive Business Growth

    Simply Wall St. via Yahoo FinanceOct 19 12:50 PM

    For example, BELLUS Health (TSE:BLU) shareholders have done very well over the last year, with the share price soaring by 170%. In light of its strong share price run, we think now is a good ...

  3. Longer term shareholders are no doubt thankful for the recovery in the share price, since it's pretty much flat for the year, even after the recent pop.

  4. Taking the occasional loss comes part and parcel with investing on the stock market. The share price is down a hefty 59% in that time. Given that Daseke didn't make a profit in the last twelve ...

  5. We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits us in the gut when we see fellow investors suffer a loss. Imagine if you ...

  6. 3 Wild Stocks to Trade This Week

    InvestorPlace via Yahoo FinanceOct 15 15:21 PM

    There is no doubt that for the last year the stock markets have often been wild. Wall Street is hostage to large swings that most often have nothing to do with the company fundamentals ...

  7. A Week In Pittsburgh, PA, On A $36,000 Stipend

    Refinery29 via Yahoo FinanceOct 19 16:00 PM

    I’m trying hard to cut down on my plastic consumption, especially since Pittsburgh doesn’t accept many kinds of “recyclable” plastic, so I make yogurt from milk bought in returnable glass bottles ...

  8. The Latest: France says no benefit in Brexit decision delay

    Associated Press via Yahoo FinanceOct 19 17:26 PM

    France's presidential Elysee Palace says there's nothing to be gained by prolonging a decision on the Brexit accord. The remarks came after British lawmakers voted to delay their decision on ...

  9. Given this risk, we thought we'd take a look at whether Editas Medicine (NASDAQ:EDIT) shareholders should be worried about its cash burn. In this article, we define cash burn as its annual ( ...

  10. Regrettably, they have had to cope with a 62% drop in the share price over that period. Unfortunately the share price momentum is still quite negative, with prices down 12% in thirty days. One ...

  1. Ads
    related to doubt